BMB Reports

Korean Society for Biochemistry and Molecular Biology (생화학분자생물학회)
권호 표지
DOI QR코드

DOI QR Code

Three novel germline mutations in MLH1 and MSH2 in families with Lynch syndrome living on Jeju island, Korea

  • Kim, Young-Mee (Department of Biochemistry, Jeju National University School of Medicine) ;
  • Choe, Chang-Gyu (Department of Biochemistry, Jeju National University School of Medicine) ;
  • KimCho, So-Mi (Faculty of Biotechnology, Jeju National University School of Medicine) ;
  • Jung, In-Ho (Faculty of Surgery, Jeju National University School of Medicine) ;
  • Chang, Won-Young (Faculty of Surgery, Jeju National University School of Medicine) ;
  • Cho, Moon-Jae (Department of Biochemistry, Jeju National University School of Medicine)
  • Received : 2010.08.06
  • Accepted : 2010.08.30
  • Published : 2010.10.31
Download PDF
⟨ Previous Next ⟩

Abstract

Hereditary non-polyposis colorectal cancer (HNPCC) is an autosomal dominant syndrome characterized by predisposition to early-onset cancers. HNPCC is caused by heterozygous loss-of-function mutations within the mismatch repair genes MLH1, MSH2, MSH6, PMS1, and PMS2. We genotyped the MLH1 and MSH2 genes in patients suffering from Lynch syndrome and in 11 unrelated patients who were diagnosed with colorectal cancer and had subsequently undergone surgery. Five Lynch syndrome patients carried germline mutations in MLH1 or MSH2. Two of these were identified as known mutations in MLH1: deletion of exon 10 and a point mutation (V384D). The remaining three patients exhibited novel mutations: a duplication (937_942dupGAAGTT) in MLH1; deletion of exons 8, 9, and 10; and a point mutation in MLH1 (F396I) combined with multiple missense mutations in MSH2 (D295G, K808E, Q855P, and I884T). The findings underline the importance of efficient pre-screening of conspicuous cases.

Keywords

References

  1. Stephenson, B. M., Finan, P. J., Gascoyne, J., Garbett, F., Murday, V. A. and Bishop, D. T. (1991) Frequency of familial colorectal cancer. Br. J. Surg. 78, 1162-1166. https://doi.org/10.1002/bjs.1800781005
  2. Wagner, A., Tops, C., Wijnen, J. T., Zwinderman, K., van der Meer, C., Kets, M., Niermeijer, M. F., Klijn, J. G., Tibben, A., Vasen, H. F. and Meijers-Heijboer, H. (2002) Genetic testing in hereditary non-polyposis colorectal cancer families with a MSH2, MLH1, or MSH6 mutation. J. Med. Genet. 39, 833-837. https://doi.org/10.1136/jmg.39.11.833
  3. Robinson, K. L., Liu, T., Vandrovcova, J., Halvarsson, B., Clendenning, M., Frebourg, T., Papadopoulos, N., Kinzler, K. W., Vogelstein, B., Peltomaki, P., Kolodner, R. D., Nilbert, M. and Lindblom, A. (2007) Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics. J. Natl. Cancer Inst. 99, 291-299. https://doi.org/10.1093/jnci/djk051
  4. Peltomaki, P. and Vasen, H. (2004) Mutations associated with HNPCC predisposition update of ICG-HNPCC/INSiGHT mutation database. DIS. Markers 20, 269-276. https://doi.org/10.1155/2004/305058
  5. Park, J. G., Kim, D. W., Hong, C. W., Nam, B. H., Shin, Y. K., Hong, S. H., Kim, I. J., Lim, S. B., Aronson, M., Bisgaard, M. L., Brown, G. J., Burn, J., Chow, E., Conrad, P., Douglas, F., Dunlop, M., Ford, J., Greenblatt, M. S., Heikki, J., Heinimann, K., Lynch, E. L., Macrae, F., McKinnon, W. C., Meeslein, G., Rossi, B. M., Rozen, P., Schofield, L., Vaccaro, C., Vasen, H., Velthuizen, M., Viel, A. and Wijnen, J. (2006) Germ line mutations of mismatch repair genes in hereditary nonpolyposis colorectal cancer patients with small bowel cancer. Clin. Cancer Res. 12, 3389-3393. https://doi.org/10.1158/1078-0432.CCR-05-2452
  6. Peltomaki, P. and Vasen, H. F. (1997) Mutations predisposing to hereditary nonpolyposis colorectal cancer database and results of a collaborative study. Gastroenterology 113, 1146-1158. https://doi.org/10.1053/gast.1997.v113.pm9322509
  7. Liu, B., Parsons, R., Papadopoulos, N., Nicolaides, N. C., Lynch, H. T., Watson, P., Jass, J. R., Dunlop, M., Wyllie, A., Peltomaki, P., de la Chapelle, A., Hamilton, S. R., Vogelstein, B. and Kinzler, K. W. (1996) Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat. Med. 2,169-174. https://doi.org/10.1038/nm0296-169
  8. Peltomaki, P., Gao, X. and Mecklin, J. P. (2001) Genotype and phenotype in hereditary nonpolyposis colon cancer: a study of families with different vs. shared predisposing mutations. Fam. Cancer 1, 9-15. https://doi.org/10.1023/A:1011564720772
  9. Aaltonen, L. A., Peltomaki, P., Leach, F. S., Sistonen, P., Pylkkanen, L., Mecklin, J. P., Jarvinen, H., Powell, S. M., Jen, J., Hamilton, S. R., Petersen, G. M., Kinzler, K. W., Vogelstein, B. and de la Chapelle, A. (1993) Clues to the pathogenesis of familial colorectal cancer. Science 260, 812-816. https://doi.org/10.1126/science.8484121
  10. Aaltonen, L. A, Salovaara, R., Kristo, P., Canzian, F., Hemminki, A., Peltomaki, P., Chadwick, R. B., Kaariainen, H., Eskelinen, M., Jarvinen, H., Mecklin, J. P. and de la Chapelle, A. (1998) Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N. Engl. J. Med. 338, 1481-1487. https://doi.org/10.1056/NEJM199805213382101
  11. Bocker, T., Cuesta, K. H., Burkholder, S., Barusevicius, A., Rose, D., Kovatich, A. J., Boman, B., Fry, R., Fishel, R. and Palazzo, J. P. (2000) Colorectal carcinomas with high microsatellite instability: defining a distinct immunologic and molecular entity with respect to prognostic markers. Hum. Pathol. 31, 1506-1514. https://doi.org/10.1053/hupa.2000.20383
  12. Chaves, P., Cruz, C., Lage, P., Claro, I., Cravo, M., Leitao, C. N. and Soares, J. (2000) Immunohistochemical detection of mismatch repair gene proteins as a useful tool for the identification of colorectal carcinoma with the mutator phenotype. J. Pathol. 191, 355-360. https://doi.org/10.1002/1096-9896(2000)9999:9999<::AID-PATH644>3.0.CO;2-T
  13. Rahner, N., Friedrichs, N., Wehner, M., Steinke, V., Aretz, S., Friedl, W., Buettner, R., Mangold, E., Propping, P. and Walldorf, C. (2007) Nine novel pathogenic germline mutations in MLH1, MSH2, MSH6 and PMS2 in families with Lynch syndrome. Acta. Oncol. 46, 763-769. https://doi.org/10.1080/02841860701230217
  14. Bronner, C. E., Baker, S. M., Morrison, P. T., Warren, G., Smith, L. G., Lescoe, M. K., Kane, M., Earabino, C., Lipford, J., Lindblom, A., Tannergard, P., Bollag, R. J., Godwin, A. R., Ward, D. C., Nordenskjold, M., Fishel, R., Kolodner, R. and Liskay, R. M. (1994) Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 368, 258-261. https://doi.org/10.1038/368258a0
  15. Papadopoulos, N., Nicolaides, N. C., Wie, Y. F., Ruben, S. M., Carter, K. C., Rosen, C. A., Haseltine, W. A., Fleischmann, R. D., Fraser, C. M., Adams., M. D., Venter, J. C., Hamilton, S. R., Petersen, G. M., Watson, P., Lynch, H. T., Peltomaki, P., Mecklin, J. P., de la Chapelle, A., Kinzler, K. W. and Volgelstein, B. (1994) Mutation of a mutL homolog in hereditary colon cancer. Science 263, 1625-1629. https://doi.org/10.1126/science.8128251
  16. Lagerstedt, R., Liu, T., Vandrovcova, J., Halvarsson, B., Clendenning, M., Frebourg, T., Papadopoulos, N., Kinzler, K. W., Vogelstein, B., Peltomaki, P., Kolodner, R. D., Nibert, M. and Lindblom, A. (2007) Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics. J. Natl. Cancer Inst. 99, 291-299. https://doi.org/10.1093/jnci/djk051
  17. Fan, Y., Wang, W., Zhu, M., Zhou, J., Peng, J., Xu, L., Hua, Z., Gao, X. and Wang, Y. (2007) Analysis of hMLH1 missense mutations in East Asian patients with suspected hereditary nonpolyposis colorectal cancer. Clin. Cancer Res. 13, 7515-7521. https://doi.org/10.1158/1078-0432.CCR-07-1028
  18. Takahashi, M., Shimodaira, H., Andreutti-Zaugg, C., Iggo, R., Kolodner, R. D. and Ishioka, C. (2007) Functional analysis of human MLH1variants using yeast and in vitro mismatch repair assays. Cancer Res. 67, 4595-4604. https://doi.org/10.1158/0008-5472.CAN-06-3509
  19. Drost, M., Zonneveld, J. B. M., Dijk, L. V., Morreau, H., Tops, C. M., Vasen, H. F. A., Wijnen, J. T. and Wind, N. D. (2010) A cell-free assay for the functional analysis of variants of the mismatch repair protein MLH1. Hum. Mutat. 31, 247-253. https://doi.org/10.1002/humu.21180
  20. Pagenstecher, C., Wehner, M., Friedl, W., Rahner, N., Aretz, S., Friedrichs, N., Sengteller, M., Henn, W., Buettner, R., Propping, P. and Mangold, E. (2006) Aberrant splicing in MLH1 and MSH2 due to exonic and intronic variations. Hum. Genet. 119, 9-22. https://doi.org/10.1007/s00439-005-0107-8
  21. Cartegni, L., Chew, S. L. and Krainer, A. R. (2002) Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat. Rev. Genet. 3, 285-298. https://doi.org/10.1038/nrg775

Cited by

  1. Clinical Evaluation of a Multiple-Gene Sequencing Panel for Hereditary Cancer Risk Assessment vol.32, pp.19, 2014, https://doi.org/10.1200/JCO.2013.53.6607
  2. Lynch-like syndrome: Characterization and comparison with EPCAM deletion carriers vol.136, pp.7, 2015, https://doi.org/10.1002/ijc.29133
  3. Distinct mutations in MLH1 and MSH2 genes in Hereditary Non-polyposis Colorectal Cancer (HNPCC) families from China vol.44, pp.5, 2011, https://doi.org/10.5483/BMBRep.2011.44.5.317
  4. Missense mutations of MLH1 and MSH2 genes detected in patients with gastrointestinal cancer are associated with exonic splicing enhancers and silencers vol.5, pp.5, 2013, https://doi.org/10.3892/ol.2013.1243
  5. Value of a molecular screening program to support clinical trial enrollment in Asian cancer patients: The Integrated Molecular Analysis of Cancer (IMAC) Study vol.142, pp.9, 2017, https://doi.org/10.1002/ijc.31091